Clinical trial
AltaValve Early Feasibility Study Protocol
NCT03997305 · 4C Medical Technologies, Inc., Industry · Unknown status
Key facts
| NCT number | NCT03997305 |
|---|---|
| Title | AltaValve Early Feasibility Study Protocol |
| Official title | AltaValve Early Feasibility Study Protocol |
| Lead sponsor | 4C Medical Technologies, Inc., Industry |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Mitral Regurgitation, Mitral Insufficiency, Mitral Valve Incompetence, Mitral Valve Regurgitation, Mitral Incompetence |
| Intervention type | Device |
| Interventions | AltaValve |
| Enrollment | 15 |
| Start date | Dec 4, 2019 |
| Primary completion | Sep 1, 2025 |
| Completion | Sep 1, 2025 |
| First posted | Jun 25, 2019 |
| Last update posted | Sep 1, 2023 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- 10–99 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: